A First-in-human Clinical Evaluation of SN132D in Patients With Breast and Pancreatic Cancer
Clinical trial NCT04080024 · COMPLETED
Trial details
- NCT number
- NCT04080024
- Sponsor
- Spago Nanomedical AB
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-23
- Primary completion
- 2022-11-30
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.